FOSTER CITY, Calif. -- Sept. 29, 2021-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that the U.S. Food and Drug Administration (FDA) has approved...
Sean McCarthy to be a panelist at CED's Business Development Partnering Forum at the NC Biotech Center in Research Triangle Park, NC.
News | 12. 10. 2007
© 2021 Pappas Capital, LLC. ALL RIGHTS RESERVED.